BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24262438)

  • 1. Molecular wanderings through the DNA damage response and risk for ovarian cancer.
    Bookman MA
    J Natl Cancer Inst; 2014 Jan; 106(1):djt350. PubMed ID: 24262438
    [No Abstract]   [Full Text] [Related]  

  • 2. RE: PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.
    Qiu H
    J Natl Cancer Inst; 2014 Apr; 106(4):dju045. PubMed ID: 24634502
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    Narod S
    J Natl Cancer Inst; 2014 Apr; 106(4):dju046. PubMed ID: 24634503
    [No Abstract]   [Full Text] [Related]  

  • 4. PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.
    Akbari MR; Lepage P; Rosen B; McLaughlin J; Risch H; Minden M; Narod SA
    J Natl Cancer Inst; 2014 Jan; 106(1):djt323. PubMed ID: 24262437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations.
    Pharoah PDP; Song H; Dicks E; Intermaggio MP; Harrington P; Baynes C; Alsop K; ; Bogdanova N; Cicek MS; Cunningham JM; Fridley BL; Gentry-Maharaj A; Hillemanns P; Lele S; Lester J; McGuire V; Moysich KB; Poblete S; Sieh W; Sucheston-Campbell L; Widschwendter M; ; Whittemore AS; Dörk T; Menon U; Odunsi K; Goode EL; Karlan BY; Bowtell DD; Gayther SA; Ramus SJ
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26823519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.
    Ali AY; Abedini MR; Tsang BK
    Oncogene; 2012 Apr; 31(17):2175-86. PubMed ID: 21927021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of protein phosphatase type 2C isoforms from retinal cDNA.
    Selke D; Klumpp S; Kaupp B; Baumann A
    Methods Mol Biol; 1998; 93():243-50. PubMed ID: 9664542
    [No Abstract]   [Full Text] [Related]  

  • 8. BAD-mediated apoptotic pathway is associated with human cancer development.
    Stickles XB; Marchion DC; Bicaku E; Al Sawah E; Abbasi F; Xiong Y; Bou Zgheib N; Boac BM; Orr BC; Judson PL; Berry A; Hakam A; Wenham RM; Apte SM; Berglund AE; Lancaster JM
    Int J Mol Med; 2015 Apr; 35(4):1081-7. PubMed ID: 25653146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHIPing out PPM1D-mutant hematopoiesis.
    Kindler T
    Blood; 2018 Sep; 132(11):1087-1088. PubMed ID: 30213836
    [No Abstract]   [Full Text] [Related]  

  • 10. Wip-ing out cancer.
    Bernards R
    Nat Genet; 2004 Apr; 36(4):319-20. PubMed ID: 15054481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Function of Proto-oncogene Product PPM1D and Development of PPM1D Inhibitors for Cancer Chemotherapy].
    Kamada R; Chuman Y; Kozakai Y; Sakaguchi K
    Seikagaku; 2015 Oct; 87(5):531-8. PubMed ID: 26638620
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of mouse protein phosphatase 2C in Escherichia coli and COS 7 cells.
    Kobayashi T; Kusuda K; Ohnishi M; Chida N; Tamura S
    Methods Mol Biol; 1998; 93():185-9. PubMed ID: 9664536
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.
    Hirasawa A; Saito-Ohara F; Inoue J; Aoki D; Susumu N; Yokoyama T; Nozawa S; Inazawa J; Imoto I
    Clin Cancer Res; 2003 Jun; 9(6):1995-2004. PubMed ID: 12796361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma.
    Reitman ZJ
    Pharmacogenomics; 2014 Sep; 15(13):1639-41. PubMed ID: 25410889
    [No Abstract]   [Full Text] [Related]  

  • 15. [Structure and function of mammalian protein phosphatase 2C].
    Tamura S; Kobayashi T; Ohnishi M; Chida N; Hanada M
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):959-67. PubMed ID: 9655952
    [No Abstract]   [Full Text] [Related]  

  • 16. The protein phosphatase 2C (PP2C) superfamily: detection of bacterial homologues.
    Bork P; Brown NP; Hegyi H; Schultz J
    Protein Sci; 1996 Jul; 5(7):1421-5. PubMed ID: 8819174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and assay of the Ptc1/Tpd1 protein phosphatase 2C from the yeast Saccharomyces cerevisiae.
    Robinson MK; Phizicky EM
    Methods Mol Biol; 1998; 93():235-42. PubMed ID: 9664541
    [No Abstract]   [Full Text] [Related]  

  • 18. A hypermorphic mutation in the protein phosphatase 2C HAB1 strongly affects ABA signaling in Arabidopsis.
    Robert N; Merlot S; N'guyen V; Boisson-Dernier A; Schroeder JI
    FEBS Lett; 2006 Aug; 580(19):4691-6. PubMed ID: 16876791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular function of protein phosphatase 2C in yeast.
    Shiozaki K; Russell P
    Cell Mol Biol Res; 1994; 40(3):241-3. PubMed ID: 7874201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of PPP2R1B gene alterations in primary ovarian cancers.
    Campbell IG; Manolitsas T
    Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.